|本期目录/Table of Contents|

[1]高 强,顾加双,徐莉莉,等.噻托溴铵联合沙美特罗/氟替卡松吸入治疗慢性阻塞性肺疾病疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2012,14(06):520-522.
　GAO Qiang,GU Jia-shuang,XU Li-li,et al.Effect of inhaled salmeterol/fluticasone and tiotropium bromide in treatment of chronic obstructive pulmonary disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(06):520-522.
点击复制

噻托溴铵联合沙美特罗/氟替卡松吸入治疗慢性阻塞性肺疾病疗效观察()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第14卷
期数:
2012年06期
页码:
520-522
栏目:
出版日期:
2012-11-20

文章信息/Info

Title:
Effect of inhaled salmeterol/fluticasone and tiotropium bromide in treatment of chronic obstructive pulmonary disease
文章编号:
1672-271X(2012)06-0520-03
作者:
高 强; 顾加双; 徐莉莉; 相 茹; 梁 娜
222042 江苏连云港，解放军82医院149临床部呼吸内科
Author(s):
GAO Qiang; GU Jia-shuang; XU Li-li; XIANG Ru; LIANG Na.
Respiratory Department,149 Clinical Branch,82 Hospital of PLA,Lianyuangang,Jiangsu 222042,China
关键词:
慢性阻塞性肺疾病; 噻托溴胺; 沙美特罗/氟替卡松; 吸入治疗
Keywords:
chronic obstructive pulmonary disease;  tiotropium bromide;  salmeterol/fluticasone;  inhalation therapy
分类号:
R563
DOI:
-
文献标志码:
A
摘要:
目的 探讨噻托溴铵联合沙美特罗/氟替卡松吸入治疗对慢性阻塞性肺疾病(COPD)的疗效。方法 76例COPD随机分为两组，对照组吸入沙美特罗/氟替卡松，观察组吸入沙美特罗/氟替卡松和噻托溴铵，其他治疗一致。3个月后比较两组治疗前后症状、FEV1(第1秒呼气量)/预计值和FEV1/FVC(用力肺活量)及血气变化。结果 两组各有36例完成治疗。治疗前两组之间各项指标无显著差异，治疗后两组自觉症状改善明显，FEV1/预计值和FEV1/FVC差异明显(P<0.01)，PaO2显著升高(P<0.01)，PaCO2降低(P<0.05)。结论 噻托溴铵联合沙美特罗/氟替卡松吸入是治疗COPD的安全有效方法。
Abstract:
Objective To evaluate the effect of inhaled sameterol/fluticasone and tiotropium bromide in treatment of chronic obstructive pulmonary disease (COPD).Methods 76 patients with COPD who had received same treatments were randomly divided into two groups with 38 patients in each group.Sameterol/fluticasone group (compared group) received inhaled sameterol/fluticasone,sameterol/fluticasone and tiotropium bromide group (treatment group) received inhaled sameterol/fluticasone and tiotropium bromide.The changes of symptom,lung function and blood gas were observed for three months in each group.Results 36 patients of each group finished the therapy.At the end of therapy,the situation of patients in each group was better than that before treatment.But the differences of value of FEV1/predictive and value of FEV1/FVC between two groups were different (P＜0.01),the differences of PaO2 and PaCO2 between two groups were different too.Conclusion The treatment of amlmeterol/fluticasone plus tiotropium bromide inhalation is safe and effective for the treatment of COPD.

参考文献/References:

[1]Seemungal TA,Donaldson GC,Bhowmik A,et al.Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease[J].Am J Respir Cril Care Med,2000,161(5):1608-1613.
[2]中华医学会呼吸病学分会.慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸病杂志，2007，30(1):8-17.
[3]陈小东.加强联合吸入治疗在慢性气道阻塞性疾病的认识[J].世界临床药物，2009，30(1):12-14.
[4]何力敏，陈于荦，张韶冈，等.噻托溴铵联合沙美特罗治疗重度慢性阻塞性肺疾病患者的疗效[J].中国老年学杂志，2011，31(20):3875-3876.
[5]陈晓毅.吸入沙美特罗氟替卡松辅助噻托嗅铵对稳定期COPD的研究[J].中国现代医生，2011，49(27):151-152.
[6]邓 锐.吸入糖皮质激素治疗稳定期COPD疗效观察[J].四川医学，2011，32(1):58-60.
[7]刘艳萍，唐冬良，刘艳明.慢性阻塞性肺疾病吸入支气管扩张剂的疗效观察[J].东南国防医药，2003，5(1):28-29.
[8]陈 萍.慢性阻塞性肺疾病稳定期的治疗[J].内科急危重症杂志，2009，15(5):230-232.
[9]Olin JL.Tiotropium:an inhaled anticholinergic chronic obstructive pulmonary disease[J].Am J Health Syst Pharm,2005,62(12):1263.
[10]Tashkin DP,Fabbri LM.Long-acting beta-agonists in the management of chronic obstructive pulmonary disease:current and future agents[J].Respir Res,2010，11:149.
[11]郑劲平，康 健，蔡 柏，等.吸入噻托溴铵干粉与异丙托溴铵定时气雾剂治疗慢性阻塞性肺疾病的疗效与安全性比较[J].中华结核和呼吸杂志，2006，29(6):363-367.

相似文献/References:

[1]吴 升,沈亚伟,郝 建,等.猪胰蛋白酶致大鼠COPD氧化应激与动脉血气间的相关性研究[J].医学研究与战创伤救治(原医学研究生学报),2012,14(03):219.
　WU Sheng,SHEN Ya-wei,HAO Jian,et al.The research of relationship between oxidatie stress and the changes of arterial blood gas in the rat with COPD induced by pig trypsin[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(06):219.
[2]胡星星,周楚瑶,钟正江,等.适应性支持通气在COPD合并呼吸衰竭患者的应用[J].医学研究与战创伤救治(原医学研究生学报),2011,13(05):412.
　HU Xing-xing,ZHOU Chu-yao,ZHONG Zheng-jiang,et al.Clinical application of adaptive support ventilation on patients with chronic obstructive pulmonary disease complicating respiratory failure[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2011,13(06):412.
[3]高 强,华 明,何海燕,等.体重指数对慢性阻塞性肺疾病并发呼吸衰竭无创机械通气治疗撤机时间的影响[J].医学研究与战创伤救治(原医学研究生学报),2010,12(03):218.
　GAO Qiang,HUA Ming,HE Hai-yan,et al.The relationship between BMI and time of noninvasive mechanical ventilation in COPD patients complicating respiratory failure[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(06):218.
[4]于海容,孟浩,许柳柳,等.淮海地区慢性阻塞性肺病急性加重期合并下呼吸道感染患者的病原菌特点及药敏分析[J].医学研究与战创伤救治(原医学研究生学报),2014,16(05):499.[doi:10.3969/j.issn.1672-271X.2014.05.017]
　YU Hai-rong,MENG Hao,XU Liu-liu,et al.Sputum etiology and drug sensitivity tests for pations with lower respiratory infection on acute exacerbation chronic obstructive pulmonary disease in Huaihai region[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(06):499.[doi:10.3969/j.issn.1672-271X.2014.05.017]
[5]龚正华,黄建安.瑞舒伐他汀对COPD患者血清白介素8及生活质量的影响[J].医学研究与战创伤救治(原医学研究生学报),2015,17(01):57.[doi:10.3969/j.issn.1672-271X.2015.01.019]
　GONG Zheng-hua,HUANG Jian-an.The observation of rosuvastatin affect on IL-8 and the quality of life on COPD patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(06):57.[doi:10.3969/j.issn.1672-271X.2015.01.019]
[6]薛迎春,顾晓燕,樊 有,等.银杏叶胶囊联合认知训练治疗稳定期慢性阻塞性肺病患者认知功能障碍临床观察[J].医学研究与战创伤救治(原医学研究生学报),2016,18(03):244.[doi:10.3969/j.issn.1672-271X.2016.03.006]
　XUE Ying-chun,GU Xiao-yan,FAN You,et al.Effects of Ginkgo biloba capsules and cognitive training on cognitive dysfunction in patients with stable chronic obstructive pulmonary disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(06):244.[doi:10.3969/j.issn.1672-271X.2016.03.006]
[7]余霓雯,王玉婷.噻托溴铵联合布地奈德福莫特罗对慢性阻塞性肺疾病的疗效及血清TGF-β、MMP-9、TIMP-1水平的影响[J].医学研究与战创伤救治(原医学研究生学报),2017,19(02):183.[doi:10.3969/j.issn.1672-271X.2017.02.018]
[8]邸婷婷综述,卞涛审校.DNA甲基化在COPD发病机制中的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2018,20(06):614.[doi:10.3969/j.issn.1672-271X.2018.06.012]
[9]李树雯,俞琦,杨凤娇,等.卡介菌多糖核酸注射液对慢性阻塞性肺疾病大鼠血清ICAM-1、TNF-α和IL-2的影响[J].医学研究与战创伤救治(原医学研究生学报),2020,22(6):578.[doi:10.3969/j.issn.1672-271X.2020.06.005]
　LI Shu-wen,YU Qi,YANG Feng-jiao,et al.Effects of pcg-pnsinjection on ICAM-1,TNF-α and IL-2 in serums of rats with COPD[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(06):578.[doi:10.3969/j.issn.1672-271X.2020.06.005]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2012-11-20